Thurston Springer Miller Herd & Titak’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7K Buy
355
+318
+859% +$20.9K 0.01% 656
2026
Q1
$2.66K Sell
37
-8
-18% -$631 ﹤0.01% 1148
2025
Q4
$3.72K Buy
45
+39
+650% +$3.04K ﹤0.01% 1144
2025
Q3
$475 Sell
6
-1,033
-99% -$77K ﹤0.01% 522
2025
Q2
$77K Sell
1,039
-301
-22% -$21K 0.01% 556
2025
Q1
$108K Buy
1,340
+36
+3% +$3.09K 0.02% 442
2024
Q4
$102K Buy
1,304
+269
+26% +$22.9K 0.02% 388
2024
Q3
$97.2K Buy
1,035
+65
+7% +$5.46K 0.03% 412
2024
Q2
$75.6K Buy
+970
New +$79.1K 0.02% 465

Other funds holding GEHC

Thurston Springer Miller Herd & Titak's GEHC Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its GE HealthCare (GEHC) stake by 859% in Q2 2026, buying an estimated $20.9K and bringing the position to 355 shares worth $22.7K. The position accounts for 0.01% of the portfolio, ranked #656.

Thurston Springer Miller Herd & Titak first reported a position in GEHC in Q2 2024 and has held it in 9 quarters since. The position peaked at $108K in Q1 2025. 443 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 355 shares of GE HealthCare worth $22.7K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 318 GE HealthCare shares in Q2 2026, an estimated $20.9K.
  • GE HealthCare made up 0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #656 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in GE HealthCare in Q2 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's GE HealthCare position peaked at $108K in Q1 2025.
  • 443 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.